SRRK
Scholar Rock Holding Corporation · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +7.1% ·
Aktienfluss +30.0% ·
neue Nettopositionen +6.7%
· Formel
Breite Akkumulation: steigende Aktienanzahl bei mehr Inhabern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 5.86K | $247,641 | n/a | n/a |
| Q2 2026 | 105 | +5 | 87.18M | $4.79B | +10 | −4 |
| Q1 2026 | 102 | +4 | 76.34M | $3.75B | +8 | −5 |
| Q4 2025 | 97 | -1 | 72.93M | $3.21B | +2 | −2 |
| Q3 2025 | 19 | -2 | 52.36M | $1.95B | n/a | −3 |
| Q2 2025 | 19 | +1 | 48.51M | $1.72B | +1 | n/a |
| Q1 2025 | 15 | 0 | 24.83M | $798.16M | n/a | n/a |
| Q4 2024 | 15 | +1 | 26.21M | $1.13B | +2 | −1 |
| Q3 2024 | 13 | 0 | 15.70M | $125.78M | +1 | −1 |
| Q2 2024 | 13 | n/a | 12.73M | $106.08M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.28M | +7.3% | $401.23M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | Marshall Wace ✦ | 2.95M | +1283.7% | $127.30M | 0.2% | ▲ Add | 3 | SEC ↗ ×3 |
| 3 | State Street Global Advisors ✦ (passiv) | 2.64M | n/a | $114.07M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (passiv) | 1.99M | +15.1% | $86.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.77M | +14.7% | $76.53M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 1.73M | +763.8% | $74.58M | 0.0% | ▲ Add | 3 | SEC ↗ ×8 |
| 7 | Citadel Advisors ✦ | 1.72M | +119.3% | $74.25M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 1.59M | Neu | $68.93M | 0.1% | New | 1 | SEC ↗ |
| 9 | Capital World Investors ✦ | 721.96K | Neu | $31.20M | 0.0% | New | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 666.88K | +240.6% | $28.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 554.74K | -24.4% | $23.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 397.55K | -35.8% | $17.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Millennium Management ✦ | 145.70K | -78.3% | $6.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 45.70K | -80.4% | $1.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 8.08K | -91.8% | $349,088 | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Adage Capital Partners | $68.93M | 0.1% |
| Capital World Investors | $31.20M | 0.0% |
Ausgestiegen
| Point72 Asset Management | $229,477 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 274 Inhaber, 132.63M Anteile, $6.20B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.